Centessa Pharmaceuticals (UK) Limited
Characterize the safety, tolerability and pharmacokinetics of ORX142 following single and multiple doses.
Key Inclusion Criteria: 1. Healthy males or females as determined by assessments at the Screening Visit. For Parts A, B, C, and E: a. Participants must be at least 18 years of age and no more than 55 years of age at the Screening 2. For Part D: a .Participants must be at least 60 years of age and no more than 80 years of age at the Screening Key Exclusion Criteria: 1. Presence of significant cardiac, pulmonary, gastrointestinal, hepatic, renal, hematological, malignancy, endocrine, neurological, or psychiatric disease, as determined by medical history, physical examination, and scr…
ORX142 Tablets
Placebo Tablets
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.